Integra Lifesciences Holdings Corp at Morgan Stanley Healthcare Conference Transcript
Let's go ahead and get started here. My name is David Lewis, Medical Device Analyst for Morgan Stanley. It's my pleasure to have with us here, as we progress through the morning in our first day of our conference, Integra Lifesciences.
And we've got 2 members of management, Peter Arduini, CEO; and Carrie Anderson, recently hired CFO. So we're going to jump right into it. Once again, please go to Morgan Stanley research disclosures website to see fun and familiar facts about me.
Questions & Answers
So Pete, I want to move right into a soup question. You've talked about this business as a 5% to 7% grower for a prolonged period of time. We didn't see that level of growth in '17, '18 or the early part here of '19. What has held the company back in terms of getting into that sort of 5% to 7% profile?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
